[go: up one dir, main page]

GB0406867D0 - Antifungal agents - Google Patents

Antifungal agents

Info

Publication number
GB0406867D0
GB0406867D0 GBGB0406867.2A GB0406867A GB0406867D0 GB 0406867 D0 GB0406867 D0 GB 0406867D0 GB 0406867 A GB0406867 A GB 0406867A GB 0406867 D0 GB0406867 D0 GB 0406867D0
Authority
GB
United Kingdom
Prior art keywords
antifungal agents
antifungal
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0406867.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F2G Ltd
Original Assignee
F2G Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F2G Ltd filed Critical F2G Ltd
Priority to GBGB0406867.2A priority Critical patent/GB0406867D0/en
Publication of GB0406867D0 publication Critical patent/GB0406867D0/en
Priority to PCT/GB2005/001146 priority patent/WO2005092304A2/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433Thidiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GBGB0406867.2A 2004-03-26 2004-03-26 Antifungal agents Ceased GB0406867D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0406867.2A GB0406867D0 (en) 2004-03-26 2004-03-26 Antifungal agents
PCT/GB2005/001146 WO2005092304A2 (en) 2004-03-26 2005-03-24 Antifungal agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0406867.2A GB0406867D0 (en) 2004-03-26 2004-03-26 Antifungal agents

Publications (1)

Publication Number Publication Date
GB0406867D0 true GB0406867D0 (en) 2004-04-28

Family

ID=32188788

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0406867.2A Ceased GB0406867D0 (en) 2004-03-26 2004-03-26 Antifungal agents

Country Status (2)

Country Link
GB (1) GB0406867D0 (en)
WO (1) WO2005092304A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7449486B2 (en) 2004-10-19 2008-11-11 Array Biopharma Inc. Mitotic kinesin inhibitors and methods of use thereof
MY158766A (en) 2005-04-11 2016-11-15 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their uses as therapeutic agents
AR053710A1 (en) 2005-04-11 2007-05-16 Xenon Pharmaceuticals Inc SPIROHETEROCICLIC COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS
UA95907C2 (en) 2005-05-02 2011-09-26 Эррей Биофарма Инк. Mitotic kinesin inhibitors and methods of use thereof
JP2009539857A (en) * 2006-06-09 2009-11-19 ワイス Thiazolidine compounds and methods of use thereof
CN101553476A (en) 2006-10-03 2009-10-07 阵列生物制药公司 Mitotic kinesin inhibitors and methods of use thereof
CN101631546A (en) 2006-10-12 2010-01-20 泽农医药公司 Use of spiro-indolone compounds as therapeutic agents
CN102077403B (en) * 2008-06-25 2013-06-19 夏普株式会社 Flame retardant-containing nonaqueous secondary battery
CA2741024A1 (en) 2008-10-17 2010-04-22 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
AU2009303468B2 (en) 2008-10-17 2014-08-28 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
AR077252A1 (en) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc ESPIROOXINDOL COMPOUND ENANTIOMERS AND THEIR USES AS THERAPEUTIC AGENTS
NZ599334A (en) 2009-10-14 2014-03-28 Xenon Pharmaceuticals Inc Synthetic methods for spiro-oxindole compounds
MY165117A (en) 2010-02-26 2018-02-28 Xenon Pharmaceuticals Inc Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
KR20140025429A (en) 2011-04-06 2014-03-04 바스프 에스이 Substituted pyrimidinium compounds for combating animal pests
WO2013033392A1 (en) * 2011-08-30 2013-03-07 Wayne State University Therapeutic compounds and methods
TW201636017A (en) 2015-02-05 2016-10-16 梯瓦製藥國際有限責任公司 Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound
WO2020214896A1 (en) * 2019-04-17 2020-10-22 University Of Maryland, Baltimore Small molecule inhibitors of gpcr gpr68 and related receptors
CN115417871B (en) * 2022-09-21 2023-06-02 成都理工大学 Double spiro pyrrolospirone oxindole compound, synthesis method and antifungal activity thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD100136A1 (en) * 1972-06-05 1973-09-12
US4699913A (en) * 1985-06-28 1987-10-13 Ciba-Geigy Corporation Substituted 4,5-dihydro-1,3,4-thiadiazoles useful as insecticides
US4812464A (en) * 1986-12-18 1989-03-14 Ciba-Geigy Corporation Pesticidal 2-pyridyl-4,5-dihydro-1,3,4-thiadiazoles
RU2083569C1 (en) * 1995-07-26 1997-07-10 Рязанский государственный медицинский университет им.акад.И.П.Павлова 2,5-diaryl-1,3,4-thiadiazolines exhibiting antidiuretic activity
AU2003214873A1 (en) * 2002-01-18 2003-09-02 Ceretek Llc Methods of treating conditions associated with an edg receptor

Also Published As

Publication number Publication date
WO2005092304A2 (en) 2005-10-06
WO2005092304A3 (en) 2006-01-26

Similar Documents

Publication Publication Date Title
IL180692A0 (en) Herbicidal agents
IL183674A0 (en) Fungicidal mixtures
GB0623209D0 (en) Antifungal agents
ZA200706006B (en) Fungicidal mixtures
IL182279A0 (en) Angiopoietin-2-specific binding agents
GB0404187D0 (en) Binding agents
IL183561A0 (en) Fungicidal mixtures
IL183676A0 (en) Fungicidal mixtures
IL177899A0 (en) Fungicidal mixtures
GB0406867D0 (en) Antifungal agents
IL183677A0 (en) Fungicidal mixtures
IL178695A0 (en) Fungicide mixtures
IL183678A0 (en) Fungicidal mixtures
ZA200607733B (en) Parasiticidal agents
IL178017A0 (en) Fungicide mixtures
IL178361A0 (en) Fungicidal mixtures
ZA200608829B (en) Fungicidal mixtures
IL178013A0 (en) Fungicidal mixtures
AP1762A (en) Fungicidal mixtures
IL176548A0 (en) Fungicide mixtures
IL178558A0 (en) Fungicide mixtures
IL177010A0 (en) Fungicidal mixtures
GB0510190D0 (en) Antifungal agents
IL177776A0 (en) Fungicidal mixtures
IL178014A0 (en) Fungicidal mixtures

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)